Control and sensation of breathing during cycling exercise in hypoxia under naloxone: a randomised controlled crossover trial
1 Sports Medicine Unit, La Tour Hospital, Meyrin, 1217, Switzerland
2 Institute of Movement Sciences and Sports Medicine, Faculty of medicine, University of Geneva, 10, rue du Conseil Général, Genève 4, 1205, Switzerland
Extreme Physiology & Medicine 2013, 2:1 doi:10.1186/2046-7648-2-1Published: 2 January 2013
Opioid receptors are possibly involved in the perception of exertion and the ventilatory response to exercise. We compared incremental cycling exercise in conditions of normoxia and hypoxia (11% O2) after injection of the opioid receptor antagonist naloxone (30 mg i.v.) or placebo. Naloxone was expected to increase sensation of breathing and cycling and to curtail exercise performance more in hypoxia.
Ten healthy subjects (29 ± 2 years, 183 ± 6 cm, 75 ± 7 kg, mean ± SD) cycled in normoxia and hypoxia until voluntary exhaustion, receiving naloxone or placebo in a balanced double-blind crossover design.
Hypoxia decreased peak power output by 37%–39% with placebo and naloxone (P < 0.001, no effect of naloxone). Switching to normoxia at exhaustion in hypoxia allowed continuing up to 97%–100% of power developed in normoxia with placebo and naloxone (P < 0.001, no effect of naloxone). Perceived exertion increased in hypoxia, dropped upon switching to normoxia and increased again towards exhaustion, no effect of naloxone. SpO2 (earlobe oximetry) was lower in hypoxia, dropping to 64%–68% with naloxone and placebo. The ventilatory response to exercise in normoxia and hypoxia was not changed by naloxone.
It follows that in healthy subjects the ventilatory response and the perception of exertion in hypoxia as compared to normoxia do not involve the endogenous opioid system, and the latter does not play a role in limiting maximum exercise capacity in hypoxia.